Kaposi's sarcoma interpreted as haematoma
Balle, J.R.; Hasselager, T.
Ugeskrift for Laeger 172(35): 2388-2389
2010
ISSN/ISBN: 1603-6824 PMID: 20825744 Document Number: 644841
Kaposi's sarcoma is a frequent skin cancer in HIV-positive patients, but is relatively uncommon in HIV-negative and non-immune compromised patients. We present a case of Kaposi's sarcoma of the face and scalp in a HIV-negative male with previous facial basal cell carcinoma.
Document emailed within 1 workday
Related Documents
Warmuth, I.; Moore, P.S. 1997: Kaposi sarcoma, Kaposi sarcoma-associated herpesvirus, and human T-cell lymphotropic virus type 1. what is the current evidence for causality? Archives of Dermatology 133(1): 83-85Olsen, S.J.; Chang, Y.; Moore, P.S.; Biggar, R.J.; Melbye, M. 1998: Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985 Aids 12(14): 1921-1925
Simonart, T.; Dobbeleer, G.D.; Peny, M.; Fayt, I.; Parent, D.; Vooren, J.; Noel, J. 1999: Pre-Kaposi's sarcoma: an expansion of the spectrum of Kaposi's sarcoma lesions European Journal of Dermatology: Ejd 9(6): 480-482
Huang, K.-M.; Hsu, C.-H.; Cheng, J.C.-H.; Lai, M.-K.; Jeng, S.-C.; Ting, L.-L.; Huang, W.-T. 2006: Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent Anticancer Research 26(6c): 4659-4663
Reinfuss, M. 1987: Kaposi's sarcoma. Clinical picture, treatment and prognosis. I. Clinical forms of Kaposi's sarcoma Nowotwory 37(3): 195-206
Murakami-Mori, K.; Mori, S.; Taga, T.; Kishimoto, T.; Nakamura, S. 1997: Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation Journal of Immunology 158(11): 5518-5526
Murakami-Mori, K.; Mori, S.; Bonavida, B.; Nakamura, S. 1999: Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells Journal of Immunology 162(6): 3672-3679
De Scoville, A. 1973: Kaposi's sarcoma Minerva Chirurgica 28(11): 862-865
Hayasaka, K.; Ishihara, K. 1985: Kaposi's sarcoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(9): 1749-1754
Ognibene, F.P.; Shelhamer, J.H. 1988: Kaposi's sarcoma Clinics in Chest Medicine 9(3): 459-465
Murugan, S. 1986: Kaposi's sarcoma Journal of the Indian Medical Association 84(10): 321
Walia, S.S.; Lee, K.; Bajoghli, A. 2007: What is your diagnosis? Kaposi sarcoma Cutis 80(5): 395 420-1
Cianfrocca, M.; Roenn, J.H. 1998: Epidemic Kaposi's sarcoma Oncology 12(9): 1375-81 1385; Discussion 1385-90
Simonart, T.; Boelaert, J.R.; Van Vooren, J.P.; Heenen, M. 2001: Iron and Kaposi's sarcoma Annales de Dermatologie et de Venereologie 128(5): 659-661
Carpenter, W.M. 1997: Case 4: Kaposi's sarcoma Journal of the California Dental Association 25(8): 559-562; 578
Beral, V. 1991: Epidemiology of Kaposi's sarcoma Cancer Surveys 10: 5-22
Morand, J.J.; Lightburn, E.; Simon, F.; Patte, J.H. 2007: Update on Kaposi's sarcoma Medecine Tropicale: Revue du Corps de Sante Colonial 67(2): 123-130
Plettenberg, A. 1991: Therapy of HIV-associated Kaposi's sarcoma Zeitschrift für Arztliche Fortbildung 85(23): 1150-1152
Coulaud, J.P. 1984: Treatment of Kaposi's sarcoma Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 77(4 Part 2): 599-603
Kogosov, I.A.; Radionov, B.V.; Konovalov, E.P.; Mezhibovskiĭ, I.G.; Apostolov, V.I.; Lomova, L.F.; Goncharova, S.I. 1990: Kaposi's sarcoma of the lung Klinicheskaia Khirurgiia 10: 58-59